JP7433245B2 - 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法 - Google Patents

皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法 Download PDF

Info

Publication number
JP7433245B2
JP7433245B2 JP2020564345A JP2020564345A JP7433245B2 JP 7433245 B2 JP7433245 B2 JP 7433245B2 JP 2020564345 A JP2020564345 A JP 2020564345A JP 2020564345 A JP2020564345 A JP 2020564345A JP 7433245 B2 JP7433245 B2 JP 7433245B2
Authority
JP
Japan
Prior art keywords
tissue
placental
composition
particles
amniotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020564345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021524436A (ja
JP2021524436A5 (https=
Inventor
レボーン，リック
アルジュノン，シバクマール
テイラー，オリビア
Original Assignee
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2021524436A publication Critical patent/JP2021524436A/ja
Publication of JP2021524436A5 publication Critical patent/JP2021524436A5/ja
Priority to JP2024016182A priority Critical patent/JP7788477B2/ja
Application granted granted Critical
Publication of JP7433245B2 publication Critical patent/JP7433245B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
JP2020564345A 2018-05-18 2019-05-20 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法 Active JP7433245B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024016182A JP7788477B2 (ja) 2018-05-18 2024-02-06 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862673528P 2018-05-18 2018-05-18
US62/673,528 2018-05-18
PCT/IB2019/054157 WO2019220421A1 (en) 2018-05-18 2019-05-20 Placental tissue component compositions for treatment of skin defects and methods using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024016182A Division JP7788477B2 (ja) 2018-05-18 2024-02-06 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法

Publications (3)

Publication Number Publication Date
JP2021524436A JP2021524436A (ja) 2021-09-13
JP2021524436A5 JP2021524436A5 (https=) 2022-05-26
JP7433245B2 true JP7433245B2 (ja) 2024-02-19

Family

ID=68533987

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020564345A Active JP7433245B2 (ja) 2018-05-18 2019-05-20 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法
JP2024016182A Active JP7788477B2 (ja) 2018-05-18 2024-02-06 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024016182A Active JP7788477B2 (ja) 2018-05-18 2024-02-06 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法

Country Status (5)

Country Link
US (2) US10849933B2 (https=)
EP (1) EP3765045B1 (https=)
JP (2) JP7433245B2 (https=)
AU (1) AU2019269210B2 (https=)
WO (1) WO2019220421A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020386363A1 (en) * 2019-11-21 2022-05-19 Bioventus, Llc . Placental tissue particulate compositions and methods of use
US20220406442A1 (en) * 2021-06-22 2022-12-22 Cerner Innovation, Inc. Donor criteria and alert notification systems
WO2024167694A2 (en) * 2023-02-06 2024-08-15 Celularity Inc. Placental extracellular matrices for ocular delivery of ophthalmic therapeutic agents
AU2024319660A1 (en) * 2023-08-08 2026-02-12 Mimedx Group, Inc. Pourable placental collagen matrix sheet
WO2025222114A1 (en) * 2024-04-18 2025-10-23 Musculoskeletal Transplant Foundation Mixtures of placental particles, grafts including them, and methods for making and using them

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009510091A (ja) 2005-09-27 2009-03-12 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US20130218274A1 (en) 2011-12-02 2013-08-22 Mimedx Group, Inc. Shredded tissue grafts and methods for making and using the same
JP2014505111A (ja) 2011-02-14 2014-02-27 ミメドックス グループ インコーポレーティッド 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
CN104055795A (zh) 2013-03-06 2014-09-24 陕西瑞盛生物科技有限公司 一种可注射植入剂及其制备方法
JP2015533095A (ja) 2012-10-08 2015-11-19 ミメディクス グループ インコーポレイテッド 骨移植片からなる微粉化組成物ならびにその製造および使用方法
JP2016529070A (ja) 2013-09-10 2016-09-23 ミメディクス グループ インコーポレイテッド 成形胎盤組成物の美容的使用
JP2016529286A (ja) 2013-08-30 2016-09-23 ミメディクス グループ インコーポレイテッド キレーターを含む微粒子化した胎盤性組成物
JP2018505189A (ja) 2015-02-11 2018-02-22 ミメディクス グループ インコーポレイテッド コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009510091A (ja) 2005-09-27 2009-03-12 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
JP2014505111A (ja) 2011-02-14 2014-02-27 ミメドックス グループ インコーポレーティッド 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
US20130218274A1 (en) 2011-12-02 2013-08-22 Mimedx Group, Inc. Shredded tissue grafts and methods for making and using the same
JP2015533095A (ja) 2012-10-08 2015-11-19 ミメディクス グループ インコーポレイテッド 骨移植片からなる微粉化組成物ならびにその製造および使用方法
CN104055795A (zh) 2013-03-06 2014-09-24 陕西瑞盛生物科技有限公司 一种可注射植入剂及其制备方法
JP2016529286A (ja) 2013-08-30 2016-09-23 ミメディクス グループ インコーポレイテッド キレーターを含む微粒子化した胎盤性組成物
JP2016529070A (ja) 2013-09-10 2016-09-23 ミメディクス グループ インコーポレイテッド 成形胎盤組成物の美容的使用
JP2018505189A (ja) 2015-02-11 2018-02-22 ミメディクス グループ インコーポレイテッド コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法

Also Published As

Publication number Publication date
EP3765045A1 (en) 2021-01-20
JP2024054213A (ja) 2024-04-16
WO2019220421A1 (en) 2019-11-21
JP2021524436A (ja) 2021-09-13
JP7788477B2 (ja) 2025-12-18
EP3765045B1 (en) 2024-08-07
EP3765045A4 (en) 2021-12-22
US10849933B2 (en) 2020-12-01
AU2019269210B2 (en) 2025-02-27
US11395837B2 (en) 2022-07-26
US20210093675A1 (en) 2021-04-01
US20190350983A1 (en) 2019-11-21
AU2019269210A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
JP7788477B2 (ja) 皮膚の欠陥の治療のための胎盤組織成分組成物およびそれを使用する方法
US11607430B2 (en) Tissue grafts composed of micronized placental tissue and methods of making and using the same
US11389565B2 (en) Molded placental tissue compositions and methods of making and using the same
US12070528B2 (en) Collagen and micronized placental tissue compositions and methods of making and using the same
US20130218274A1 (en) Shredded tissue grafts and methods for making and using the same
KR20240042159A (ko) 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
TW201427671A (zh) 招集及定位幹細胞之組合物及方法
JP2016529070A (ja) 成形胎盤組成物の美容的使用
US20230347015A1 (en) Lyophilized perforated placental membrane tissue grafts
WO2025034980A1 (en) Pourable placental collagen matrix sheet

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220518

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230524

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230727

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231213

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240206

R150 Certificate of patent or registration of utility model

Ref document number: 7433245

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150